Accession Number: | 0001213900-22-034071 |
Date: | 2022-06-16 |
Issuer: | AUGMEDIX, INC. (AUGX) |
Original Submission Date: |
TRAYLOR MARGIE L.
C/O AUGMEDIX, INC.
111 SUTTER STREET, SUITE 1300
SAN FRANCISCO, CA 94104
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 1.9 | 2022-06-16 | deemed execution date | A | 52,632 (a) | common stock 52,632 | $1.90 | 52,632 | direct |
ID | footnote |
---|---|
f1 | the restricted stock unit ("rsu") is granted under the augmedix, inc. (the "issuer") 2020 equity incentive plan. each rsu represents a contingent right to receive one share of issuer's common stock. |
f2 | the rsu will vest in full on the one-year anniversary of june 16, 2022, so long as the reporting person remains a director on such date. |